These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35727057)

  • 1. Parasite Viability as a Measure of
    Radohery GFR; Walz A; Gumpp C; Cherkaoui-Rbati MH; Gobeau N; Gower J; Davenport MP; Rottmann M; McCarthy JS; Möhrle JJ; Rebelo M; Demarta-Gatsi C; Khoury DS
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0011422. PubMed ID: 35727057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans.
    Rebelo M; Pawliw R; Gower J; Webb L; Mitchell H; Pava Z; Watts RE; Davenport MP; McCarthy JS; Khoury DS
    J Infect Dis; 2021 Jun; 223(12):2154-2163. PubMed ID: 33119072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
    PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
    Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
    J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
    Saunders D; Khemawoot P; Vanachayangkul P; Siripokasupkul R; Bethell D; Tyner S; Se Y; Rutvisuttinunt W; Sriwichai S; Chanthap L; Lin J; Timmermans A; Socheat D; Ringwald P; Noedl H; Smith B; Fukuda M; Teja-Isavadharm P
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5484-93. PubMed ID: 22869581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
    Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
    Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the antimalarial activity of artesunate.
    Adebayo JO; Tijjani H; Adegunloye AP; Ishola AA; Balogun EA; Malomo SO
    Parasitol Res; 2020 Sep; 119(9):2749-2764. PubMed ID: 32638101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia.
    Maude RJ; Silamut K; Plewes K; Charunwatthana P; Ho M; Abul Faiz M; Rahman R; Hossain MA; Hassan MU; Bin Yunus E; Hoque G; Islam F; Ghose A; Hanson J; Schlatter J; Lacey R; Eastaugh A; Tarning J; Lee SJ; White NJ; Chotivanich K; Day NP; Dondorp AM
    J Infect Dis; 2014 Jan; 209(1):120-9. PubMed ID: 23943850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
    Chotivanich K; Udomsangpetch R; Dondorp A; Williams T; Angus B; Simpson JA; Pukrittayakamee S; Looareesuwan S; Newbold CI; White NJ
    J Infect Dis; 2000 Aug; 182(2):629-33. PubMed ID: 10915102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
    Jones S; Hodel EM; Sharma R; Kay K; Hastings IM
    J Infect Dis; 2019 Apr; 219(8):1243-1253. PubMed ID: 30517708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria Parasite Clearance: What Are We Really Measuring?
    Khoury DS; Zaloumis SG; Grigg MJ; Haque A; Davenport MP;
    Trends Parasitol; 2020 May; 36(5):413-426. PubMed ID: 32298629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens.
    Hoshen MB; Na-Bangchang K; Stein WD; Ginsburg H
    Parasitology; 2000 Sep; 121 ( Pt 3)():237-46. PubMed ID: 11085244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
    Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
    Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.